Acuitas: (noun) insight, perception, sharpness.

NEWSROOM

NEWS AND EVENTS

VIDEO ALERT

  • Jun. 9, 2020 – Click to see a short video on how the Acuitas Therapeutics’ lipid nanoparticle triggers uptake into a cell. Link

American Institute for Medical and Biological Engineering (AIMBE)

  • Mar. 30, 2020 – Our President and CEO, Dr. Thomas Madden, has been inducted into the very prestigious AIMBE College of Fellows for his “outstanding contributions to the field of nucleic acid delivery and exemplary leadership in lipid nanoparticle product development and commercialization.” Link

2019 mRNA HEALTH CONFERENCE

PUBLICATION ALERT

  • Jan. 30, 2020 – Collaboration with Dr. Muzykantov in the development of mRNA-LNP targeting cerebral Vasculature. (Proc Natl Acad Sci U S A. 2020). Link
  • Jan. 30, 2020 – Collaboration with Dr. Hensley in the development of mRNA-LNP vaccine for infants. (Sci Transl Med. 2020). 2020). Link
  • Sep. 20, 2019 – Collaboration with Dr. Sanders in the delivery of self-amplifying mRNA with LNPs (Mol Ther Nucleic Acids 2019). Link
  • April 12, 2019 – Collaboration with Dr. Weissman in the development of mRNA-LNP for HIV vaccine (Mol Ther Nucleic Acids 2019). Link
  • April 12, 2019 – Collaboration with Dr. Lee and colleagues in the development of ZFN mRNA-LNP for in vivo genome editing (Mol Ther 2019). Link
  • Nov. 22, 2018 – Collaboration with Dr. Muzykantov in the development of targeting mRNA-LNP (J Control Release 2018). Link
  • April 12, 2019 – Collaboration with Dr. Weissman in the development of mRNA-LNP for HIV vaccine (Mol Ther.Nucleic Acids). Link
  • April 12, 2019 – Collaboration with Dr. Lee and colleagues in the development of ZFN mRNA-LNP for in vivo genome editing (Mol Ther 2019). Link
  • Nov. 22, 2018 – Collaboration with Dr. Muzykantov in the development of targeting mRNA-LNP (J Control Release. 2018 Dec 10;291:106-115.). Link

2018 mRNA HEALTH CONFERENCE

  • Nov. 12, 2018 – We will be presenting at the upcoming 6th International mRNA Health conference Nov. 12-13 in Boston, MA “Characterizing the therapeutic application of messenger RNA-lipid nanoparticles”

RE-LAUNCH OF ACUITAS WEBSITE

  • Nov. 9, 2018 – Acuitas re-launches website on Nov. 9, 2018

PUBLICATION ALERT

  • Aug. 22, 2018 – Collaboration with Dr. Weissman in the development of broadly protective/universal influenza virus vaccine using mRNA-LNP (Nat Commun. 2018 Aug 22;9(1):3361). Link